<DOC>
	<DOCNO>NCT01976689</DOCNO>
	<brief_summary>New-onset diabetes ( NODAT ) solid organ transplantation important clinical challenge associate increase risk cardiovascular ( CV ) event . In end-stage renal disease ( ESRD ) patient , impact arterial stiffness all-cause CV mortality clearly document . Arterial stiffness pivotal role genesis high blood pressure ( SBP ) , increase leave ventricular hypertrophy ( LVH ) , consequently CV mortality . Both LVH arterial stiffness independent determinant CV disease patient ESRD . The aim study evaluate relationship post-transplant new-onset diabetes arterial stiffness leave ventricular mass index ( LVMI ) kidney transplant recipient .</brief_summary>
	<brief_title>New-onset Diabetes Left Ventricular Hypertrophy Renal Transplantation</brief_title>
	<detailed_description>All patient ' data record clinical chart . Visits patient clinic organize follow : three visit per week first 2 week ; two visit per week day 60 ; weekly visit day 120 ; monthly visit first year ; one visit every month second year ; four visit per year thereafter death end-stage renal disease ( i.e . dialysis retransplantation ) . The following parameter collect ; 1 ) age , 2 ) gender , 3 ) posttransplantation duration , 4 ) pretransplant hemodialysis duration , 4 ) acute rejection episode , 5 ) use statin , ace inhibitor ( ACE ) angiotensin receptor blocker ( ARB ) , 6 ) immunosuppressive treatment ( mycophenolate , cyclosporine , tacrolimus , sirolimus use ) , 7 ) pretransplant lipid profile ( value last month transplantation ) , 8 ) posttransplant lipid profile ( mean value ) , 9 ) FPG HbA1c level ( mean value ) , 10 ) office blood pressure measurement , 11 ) hemoglobin , calcium , phosphorus , albumine parathyroid hormone level , 12 ) creatinine estimate GFR ( MDRD equation ) , 13 ) cytomegalovirus ( CMV ) infection history . Mean value arithmetic mean parameter collect patient chart 3 monthly basis first posttransplant 6 month parameter ( 12-16 ) collect single value study inclusion . All patient 5 mg prednisolone treatment within immuno suppressive regimen . Maintenance immunosuppressive treatment include prednisone gradual tapering mycophenolate mofetil sodium associate cyclosporine , tacrolimus sirolimus patient . Target level 3 month 150-250 ng/ml cyclosporine 8-12 ng/ml tacrolimus sirolimus . Anti-diabetic treatment modality ( diet lifestyle change , oral anti-diabetic drug insulin ) also record patient NODAT . Body compositions patient analyzed use Body Composition Analyzer ( Tanita BC-420MA ) . Fat mass , fat free mass , muscle mass , visceral fat mass body mass index calculate patient . All patient underwent echocardiographic examination ( Siemens Acuson C256 , Mountain view , California 2000 3V2c transducer probe ) operator leave ventricular mass calculate accord Devereux formula indexed body surface area give LVMI ( g/m2 ) . Left ventricular mass index value great 130g/m2 ( n : 57 ) define high leave ventricular mass . Pulse wave velocity ( PWv ) define velocity arterial pulse move along vessel wall . Pulse wave velocity along aorta measure use two ultrasound pressure sensitive transducer fix transcutaneously course pair artery separate known distance : femoral right common carotid artery . PWV calculate measurement pulse transit time distance , accord follow formula : PWV ( m/s ) = distance ( ) /transit time ( ) . Measurement PWV value con-ducted abstinence caffeine smoke overnight fast without intake antihypertensive drug . PWV determine use SphygmoCor CvMs V9 system value &gt; 7 m/s define increase .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<criteria>Patients underwent renal transplantation year 20072010 transplantation clinic routine periodical followup . irregular drug usage patient incompliance lack regular followup data pretransplant diabetes mellitus history bone marrow transplant solid organ time transplantation ( include previous kidney transplantation ) malign disease , rheumatologic chronic inflammatory disease unknown origin , systemic vasculitis history acute rejection period first year transplantation unstable cardiac disease include heart failure ( ejection fraction &lt; % 50 ) and/or ischemic heart disease history ( myocardial infarction , need cardiac revascularization ) atrial fibrillation elevate heart rate ( &gt; 100 beats/min ) coronary bypass transplantation transiently elevate fast plasma glucose ( FPG ) diabetic blood glucose profile first 3 posttransplant month graft failure [ glomerular filtration ( GFR ) rate &lt; 30 mL/min ] history peritoneal dialysis transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Glucose Regulation</keyword>
	<keyword>Left Ventricular Hypertrophy</keyword>
	<keyword>New-onset Diabetes</keyword>
	<keyword>Renal Transplantation</keyword>
</DOC>